Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Fintech PR

Irish-US Company Celtic Biotech in French cancer venom trials reports grant boost

Published

on

DUBLIN, July 18, 2023 /PRNewswire/ — Irish company Celtic Biotech Ltd (www.celticbiotech.com) has been awarded a grant of €2.5m from the EU European Innovation Council (EIC) Accelerator programme.

 

 

 Dr. Paul Reid, CEO and co-founder at Celtic Biotech said:

“We are very pleased to be approved by the EIC for this prestigious European Commission grant award. This is a major validation of our business and product strategy and is in alignment with Europe’s Beating Cancer Plan. Our innovative biologic products will treat cancer patients with advanced disease. Our pre-clinical and clinical investigations to date point to a drug with enormous potential to target aggressive solid tumours and associated pain in cancer patients. The EIC Accelerator grant funding will enable us complete our Phase I clinical programme, a vital step closer to achieving that potential”.

In Q1 2023 the EIC Fund became the biggest venture capital investor in European deals measured by amount invested, and third in number of deals. Since its launch in 2020, the EIC Fund has approved a total of 268 equity investments into deep-tech companies for a total of €1.4B.

According to Enterprise Ireland’s National Director for Horizon Europe, Kevin Burke, the selection of companies for EIC Accelerator grant and equity investment follows a rigorous evaluation and selection process by an independent panel of experts, and due diligence by the European Investment Bank (EIB), in its role of Investment Advisor.

John Reid, Co-founder and Director, stated the Company plans to seek follow-on EIC Accelerator Equity investment of up to €15m post successful Phase I trials in conjunction with strategic investors.

In further recognition and validation of it’s exciting potential, Celtic Biotech was also successful this month in reaching the semi-finals of the prestigious European Institute of Innovation and Technology (EIT) Catapult accelerator programme. This EU co-funded programme is designed to fast-track Europe’s best life sciences and health tech start-ups to leading experts and investors.  Semi-finalists get to pitch to international investors and world leading companies whilst also competing for cash awards, and the Audience Winner Award to have their startup showcased on the New York NASDAQ Tower.

Brothers Paul, based in Florida, and John in Ireland, formed Celtic Biotech to develop curative cancer therapies for terminally ill patients with few or no options left to turn to. Using proteins isolated from rattlesnake venom, Celtic Biotech succeeded in bringing its lead drug, CB24, into Phase I clinical trials in France under the supervision of renowned oncologists Dr Miguel Delgado and Dr Marian Gil-Delgado. Prof. John Crown (Ireland) and Prof. David Khayat (France) were advisors on the trial protocol. Published studies report exceptionally good safety profiles with several tumour responses in 14 patients treated.  Clinical monitoring was conducted by Immunoclin UK. Raw venom sourced via a collaboration with CITES registered Kentucky Reptile Zoo, USA.

Advertisement

Every year 4million Europeans are diagnosed with cancer and 1.9million die because of it. Worldwide the figure for annual deaths is 10million, with the USA accounting for over 600,000.

Media Contact – [email protected]www.celticbiotech.com

 

Rattlesnake baby_Celtic Biotech Colony_Kentucky Reptile Zoo

 

Celtic Biotech Logo

 

Video – https://mma.prnewswire.com/media/2155848/Celtic_Biotech.mp4
Photo – https://mma.prnewswire.com/media/2155737/Celtic_Biotech.jpg
Logo – https://mma.prnewswire.com/media/2155739/Celtic_Biotech_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/irish-us-company-celtic-biotech-in-french-cancer-venom-trials-reports-grant-boost-301879022.html

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

UnionPay International Powers CIIE with Enhanced Cross-border Payment Solutions, Boosting Cross-border Trade Payments

Published

on

unionpay-international-powers-ciie-with-enhanced-cross-border-payment-solutions,-boosting-cross-border-trade-payments

SHANGHAI, Nov. 14, 2024 /PRNewswire/ — The 7th China International Import Expo (CIIE) opened on November 5, welcoming nearly 3,500 exhibitors from 129 countries and regions. UnionPay International (UPI), a longstanding partner of CIIE, showcased its commitment to facilitating global trade by delivering cutting-edge, secure, and convenient payment solutions for exhibitors, buyers, and visitors.

Enhancing Payment Experiences for Global Participants

During this year’s CIIE, UPI unveiled its latest payment innovations, including the UnionPay SplendorPlus Card and the CIIE-themed Card, at the Bank of China (BOC) Shanghai Pavilion. These products attracted significant attention from domestic and international attendees, emphasizing seamless and tailored payment experiences for cross-border transactions.

As part of its broader “Project Excellence 2024”, launched earlier this year, UPI introduced the SplendorPlus Card, specifically designed for inbound international travelers. This versatile card supports multiple payment methods—physical card, QR code, and mobile payments—and offers exclusive benefits such as cashback and localized privileges across five key categories, including transportation, cultural attractions, and dining. With nearly 40 financial institutions worldwide now issuing or preparing to issue the card, UPI continues to expand its reach, enhancing connectivity between China and the global market.

Meeting Evolving Cross-border Payment Needs

UPI’s payment ecosystem has grown significantly in recent years, driven by technological innovation and an understanding of diverse global consumer preferences. To date, more than 250 million UnionPay cards have been issued in 83 countries and regions. Cardholders can access comprehensive payment services within China, including dining, retail, hotel bookings, and transportation, such as Shanghai metro ticketing and taxi services.

In addition, UPI has partnered with over 200 e-wallet providers in 36 countries and regions, enabling international users to link UnionPay cards or apply for digital cards for contactless and mobile payments, mirroring the convenience enjoyed by local residents.

To further support domestic exhibitors and buyers traveling abroad, UPI has launched a CIIE-themed card in collaboration with BOC Shanghai. This card offers domestic users a 1% cashback benefit, along with exclusive discounts at brick-and-mortar merchants in 20 countries and regions, meeting the growing demands of outbound travelers.

Driving Innovation in Cross-border Trade

Beyond enhancing payment experiences for individuals, UPI is at the forefront of driving innovation in cross-border trade. Following the State Council’s approval to establish a Silk Road E-commerce Pilot Zone in Shanghai, UPI has collaborated with key industry players to develop digital payment solutions based on cross-border electronic invoices. This initiative integrates customs declaration, invoicing, and payment settlement processes into a unified digital ecosystem, fostering transparency and efficiency in global trade.

Advertisement

At the Silk Road E-commerce Innovation & Development Conference, held as part of CIIE on November 7, UPI signed a memorandum of understanding with Shanghai E&P International, BoComm Shanghai, and BOC Shanghai. This collaboration marks a pivotal step in aligning Shanghai with international trade standards and promoting the adoption of electronic documentation in global commerce.

Under the guidance of regulatory authorities, UPI has pioneered standardized and compliant end-to-end solutions to address the evolving needs of cross-border e-commerce. From international airfare and hotel payments to online transactions and settlements, these solutions empower businesses to embrace digital transformation, contributing to the sustainable development of global trade.

View original content:https://www.prnewswire.co.uk/news-releases/unionpay-international-powers-ciie-with-enhanced-cross-border-payment-solutions-boosting-cross-border-trade-payments-302305088.html

Continue Reading

Fintech PR

Gentoo Media – Mandatory notification of trade

Published

on

gentoo-media-–-mandatory-notification-of-trade

ST JULIANS, Malta, Nov. 14, 2024 /PRNewswire/ — MJ Foundation Fundacja Rodzinna, a company related to Mateusz Juroszek, Board Member and primary insider of Gentoo Media Inc. (Gentoo) has today acquired 115,604 shares in Gentoo at a price of SEK 24,996 per share. After this transaction, close associates of Mateusz Juroszek hold 24,027,766 shares in Gentoo.

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

For further information, contact:
Tore Formo, Group CFO, [email protected], +47 91668678

About Gentoo Media

Gentoo Media is a market-leading affiliate connecting operators and players in the online gambling and sports betting industry. Gentoo Media offers an array of iGaming affiliate solutions, such as paid marketing expertise and quality traffic through our prominent industry sites including AskGamblers, Time2Play, CasinoTopsOnline, WSN and Casinomeister. In 2024, Gentoo Media (formerly GiG Media) became Gentoo Media Inc. following a legal split separating the Media and Platform and Sportsbook business in Gaming Innovation Group (GiG) into two independently listed companies. Gentoo Media Inc. is dual listed on the Oslo Stock Exchange (ticker “G2MNO”) and Nasdaq Stockholm (ticker “G2M”). www.gentoomedia.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/gentoo-media-inc/r/gentoo-media—mandatory-notification-of-trade,c4066199

View original content:https://www.prnewswire.co.uk/news-releases/gentoo-media—mandatory-notification-of-trade-302305030.html

Continue Reading

Fintech PR

Newmark Advises URW in €172.5 Million Office Sale

Published

on

newmark-advises-urw-in-e172.5-million-office-sale

PARIS, Nov. 13, 2024 /PRNewswire/ — Newmark announces the firm has advised Unibail-Rodamco-Westfield (URW) in the €172.5 million sale of the 140,846 square-foot (13,085 square-meter) office portion of Les Ateliers Gaîté, a mixed-use property in the prominent Montparnasse district of Paris. Newmark Deputy Chief Business Officer Emmanuel Frénot arranged the transaction between URW and buyers Swiss Life Asset Managers and Norges Bank Investment Management.

“Advising URW on the sale of this asset, with its exceptional location and exemplary environmental approach, just a few months after the opening of our Paris office makes us particularly proud and highlights our ongoing momentum,” said Frénot. “This transaction confirms the recovery signals we have been sensing since the end of the second quarter of 2024 and suggests an increase in activity in the office segment for 2025.”

Les Ateliers Gaîté, delivered in 2022, includes around 100 retail shops, restaurants and services, as well as a hotel, offices, housing and a public library. The office space is leased long-term to coworking operator Wojo, establishing its Parisian flagship.

Newmark opened its flagship Paris office in March, hiring several of the city’s most respected brokers, including Francois Blin and Frénot to lead the team, Antoine Salmon and Vianney d’Ersu as Co-Heads of Retail Leasing, Managing Directors Jérôme De Laboulaye, Nicolas Coutant and Alexandre Gotti as President, France. The office is now home to nearly 40 leading French commercial real estate professionals, including a market-leading research team.

About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries (“Newmark”), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark’s comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform’s global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. For the twelve months ended September 30, 2024, Newmark generated revenues of over $2.6 billion. As of that same date, Newmark’s company-owned offices, together with its business partners, operated from nearly 170 offices with more than 7,800 professionals around the world. To learn more, visit nmrk.com or follow @newmark.

Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are “forward-looking statements” that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company’s business, results, financial position, liquidity, and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark’s Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.

Logo – https://mma.prnewswire.com/media/1057994/Newmark_Group_Logo_v1.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/newmark-advises-urw-in-172-5-million-office-sale-302304709.html

Continue Reading
Advertisement
Advertisement European Gaming Congress 2024

Latest news

Trending